3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
86
Colonic Neoplasms
32
Rectal Neoplasms
31
Neoplasms
24
Pancreatic Neoplasms
22
Stomach Neoplasms
20
Neoplasm Metastasis
20
Esophageal Neoplasms
20
Neuroblastoma
12
Glioma
11
Sarcoma
9
Glioblastoma
9
Small Cell Lung Carcinoma
8
Carcinoma, Non-Small-Cell Lung
8
Brain Neoplasms
8
Adenocarcinoma Of Esophagus
8
Rhabdomyosarcoma
7
Lung Neoplasms
7
Sarcoma, Ewing
6
Gliosarcoma
6
Esophageal Squamous Cell Carcinoma
6
Medulloblastoma
5
Central Nervous System Neoplasms
5
Breast Neoplasms
5
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Intestinal Neoplasms
4
Gastrointestinal Neoplasms
4
Digestive System Neoplasms
4
Digestive System Diseases
4
Adenocarcinoma
4
Interventions
lutetium Lu 177 dotatate
2
pembrolizumab
1
pasireotide
1
lanreotide
1
folfirinox
1
copper dotatate CU-64
1
arginyllysine
1
Receptor-Like Protein Tyrosine Phosphatases, Class 2
1
Octreotide
1
Nivolumab
1
Lutetium-177
1
Lutetium
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Etoposide
1
Cytokines
1
Cryotherapy
1
Carboplatin
1
Acupuncture Therapy
1
Acupressure
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Gastro-enteropancreatic neuroendocrine tumor
×
Irinotecan
×
Clear all
No trials found.